Medigen develops novel vaccine technologies that provide inherent biological safety and unsurpassed efficacy to our vaccines. We apply methods of molecular biology, protein engineering and molecular virology for the development of conceptually new vaccine approaches. Our proprietary technologies are focused on safety and natural immunity.
Medigen vaccines resemble natural viruses while being safe and inducing natural, long-lasting immune responses. Our technologies include: